From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA
VJOncologyVJ Oncology@VJOncology·
December 3, 2022

🎥 Anant Madabhushi (@anantm) of @EmoryMedicine talks on delta-radiomics predicting response and overall-survival in advanced non-small cell lung cancer treated with durvalumab

Watch: 👉http://ow.ly/x7hc50LTAKJ👈

@sitcancer #SITC2022 #SITC22 #ImmunoOnc

Reply on Twitter 1599071455869902852Retweet on Twitter 15990714558699028521Like on Twitter 1599071455869902852Twitter 1599071455869902852
VJOncologyVJ Oncology@VJOncology·
December 3, 2022

🔈Check out our latest podcast covering updates in EGFR-mutant #NSCLC !!

Listen here: 🎧 http://ow.ly/6RhS50LTAC7 🎧

#LungCancer @CharlesSwanton @LimEmilia @DrSanjayPopat @HazelOSulliva14 @JuliaRotow @BiagioMd

Reply on Twitter 1599026013983457281Retweet on Twitter 1599026013983457281Like on Twitter 1599026013983457281Twitter 1599026013983457281
VJOncologyVJ Oncology@VJOncology·
December 3, 2022

🎥 Saman Maleki (@SMImmunology) of @WesternU talks on the correlation between the composition of the gut microbiota with anti-PD-1 efficacy in cancer patients

Watch: 👉http://ow.ly/3MuL50LTAuo👈

@sitcancer #SITC2022 #SITC22 #ImmunoOnc

Reply on Twitter 1598980742859706368Retweet on Twitter 15989807428597063681Like on Twitter 15989807428597063681Twitter 1598980742859706368
VJOncologyVJ Oncology@VJOncology·
December 3, 2022

It's Day 2 of #ESMOAsia22!

We’ve heard some fascinating talks so far - head over to http://VJOncology.com to check out some of our interviews and stay tuned for more updates 🩺🔬💻

@myESMO

Reply on Twitter 1598950502791892992Retweet on Twitter 1598950502791892992Like on Twitter 1598950502791892992Twitter 1598950502791892992
Load More

GU Cancers 2022

ASCO Genitourinary Cancers Symposium
17–19 February 2022 | San Francisco, CA
From world-class science to patient-centered care, the 2022 ASCO Genitourinary (GU) Cancers Symposium offered new, innovative findings in the study, diagnosis, and treatment of GU malignancies.   Catch up on key trials in prostate, bladder and kidney cancer, including findings from the PROpel, ARASENS, and BAYOU studies and more.
View all videos
VJOncologyVJ Oncology@VJOncology·
December 3, 2022

🎥 Anant Madabhushi (@anantm) of @EmoryMedicine talks on delta-radiomics predicting response and overall-survival in advanced non-small cell lung cancer treated with durvalumab

Watch: 👉http://ow.ly/x7hc50LTAKJ👈

@sitcancer #SITC2022 #SITC22 #ImmunoOnc

Reply on Twitter 1599071455869902852Retweet on Twitter 15990714558699028521Like on Twitter 1599071455869902852Twitter 1599071455869902852
VJOncologyVJ Oncology@VJOncology·
December 3, 2022

🔈Check out our latest podcast covering updates in EGFR-mutant #NSCLC !!

Listen here: 🎧 http://ow.ly/6RhS50LTAC7 🎧

#LungCancer @CharlesSwanton @LimEmilia @DrSanjayPopat @HazelOSulliva14 @JuliaRotow @BiagioMd

Reply on Twitter 1599026013983457281Retweet on Twitter 1599026013983457281Like on Twitter 1599026013983457281Twitter 1599026013983457281
VJOncologyVJ Oncology@VJOncology·
December 3, 2022

🎥 Saman Maleki (@SMImmunology) of @WesternU talks on the correlation between the composition of the gut microbiota with anti-PD-1 efficacy in cancer patients

Watch: 👉http://ow.ly/3MuL50LTAuo👈

@sitcancer #SITC2022 #SITC22 #ImmunoOnc

Reply on Twitter 1598980742859706368Retweet on Twitter 15989807428597063681Like on Twitter 15989807428597063681Twitter 1598980742859706368
VJOncologyVJ Oncology@VJOncology·
December 3, 2022

It's Day 2 of #ESMOAsia22!

We’ve heard some fascinating talks so far - head over to http://VJOncology.com to check out some of our interviews and stay tuned for more updates 🩺🔬💻

@myESMO

Reply on Twitter 1598950502791892992Retweet on Twitter 1598950502791892992Like on Twitter 1598950502791892992Twitter 1598950502791892992
Load More
Prostate Cancer Bladder Cancer Kidney Cancer

Latest videos

View all
3:07
PROpel: olaparib plus abiraterone as 1L treatment for metastatic CRPC
Fred Saad • 17 Feb 2022
1:35
ARCHES: OS by high or low disease volume and progression to mHSPC or de novo mHSPC
Andrew Armstrong • 17 Feb 2022
1:34
Combination therapies for the treatment of prostate cancer
Fred Saad • 17 Feb 2022
1:19
An AI biomarker to aid in the decision of treatment with ADT for localized prostate cancer
Andrew Armstrong • 17 Feb 2022
VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals